Physician profile
Jaime Shuff
NPI 1275627002
$647.93
in general payments reported to CMS, 2019-2025
11 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.18 · 2021: $24.59 · 2022: $32.64 · 2023: $288 · 2024: $146 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accuray Incorporated | $131.98 | 2023 | Cyberknife System |
| Brainlab, INC. | $122.91 | 2023 | Image Guided Surgical Device |
| Novartis Pharmaceuticals Corporation | $76.94 | 2024-2025 | |
| Reflexion Medical, INC. | $74.33 | 2024 | Reflexion Medical Radiotherapy System |
| Siemens Medical Solutions USA, INC. | $53.27 | 2022-2024 | Varian Ethos Treatment Planning |
| Angiodynamics, INC. | $52.77 | 2019-2021 | |
| Novocure INC. | $48.95 | 2023-2025 | Optune Lua (Novottf-200t), Optune |
| Progenics Pharmaceuticals, INC. | $27.92 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $23.47 | 2025 | Libtayo |
| Nestle Healthcare Nutrition INC. | $17.89 | 2023 | |
| Boston Scientific Corporation | $17.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Shuff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.